Imatinib Mesylate or Dasatinib in Treating Patients With Previously Untreated Chronic Phase Chronic Myelogenous Leukemia
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Takeda
St. Jude Children's Research Hospital
M.D. Anderson Cancer Center
Masonic Cancer Center, University of Minnesota
Montefiore Medical Center
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
H. Lee Moffitt Cancer Center and Research Institute
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Incyte Corporation
City of Hope Medical Center
City of Hope Medical Center
Novartis
M.D. Anderson Cancer Center
Thomas Jefferson University
Incyte Corporation
Imago BioSciences, Inc., a subsidiary of Merck & Co., Inc., (Rahway, New Jersey USA)
PharmaEssentia Japan K.K.
Novartis
National Cancer Institute (NCI)
Novartis
Weill Medical College of Cornell University
Incyte Corporation
Masonic Cancer Center, University of Minnesota
OHSU Knight Cancer Institute
City of Hope Medical Center
M.D. Anderson Cancer Center
Center for International Blood and Marrow Transplant Research
Masonic Cancer Center, University of Minnesota
Roswell Park Cancer Institute
Weill Medical College of Cornell University
City of Hope Medical Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
City of Hope Medical Center
Masonic Cancer Center, University of Minnesota
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center
Thomas Jefferson University
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center